⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge
globenewswire.com
AZN
MRK
BMY
PFE
AMGN
Genova Diagnostics Names Keith Meadors Chief Commercial Officer to Support Next Phase of Growth
prnewswire.com
LH
PFE
BDX
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
prnewswire.com
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
U.S. Chamber Discusses How Medical Breakthroughs Are Extending Lives and Strengthening the Economy with YourUpdateTV
globenewswire.com
MRK
PFE
JNJ
BMY
GILD
LLY
AMGN
REGN
ABBV
BIIB
Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity
globenewswire.com
PFE
SNY
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris
globenewswire.com
ABBV
AMGN
PFE
VTRS
$3.36 Trn AI in Medicine Market Research and Global Forecasts, 2026-2040: Google DeepMind, IBM Watson Health, NVIDIA, Tempus, and PathAI Dominate Through Substantial Investments
globenewswire.com
GOOGL
IBM
NVDA
PFE